CRI.WAR Creotech Instruments S.A.
- Market cap
- PLN 2.90B
- P/E
- 136.3x
- P/B
- 19.45x
- ROE
- 2.8%
- Dividend yield
- -
- Fundamental score
- 1.8/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is CRI.WAR undervalued?
Graham numberThe Graham number of Creotech Instruments S.A. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Creotech Instruments S.A. fundamental analysis
8 of 22 checks passedROE 0/2
Low return on equity (2.8%), below 10%.
ROA 0/1
Return on assets (1.4%) is below the industry median (2.7%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (158.1%) is above the 5-year average (34.9% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (158.1%) is above the industry median (18.3%).
Revenue Growth 2/2
Revenue grew 92.4% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (15.9%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 0/1
EBIT is negative, against interest expense, below 5x.
PE vs Market 0/1
PE (134.6x) is above the market median (11.6x).
PE vs Industry 0/1
PE (134.6x) is above the industry median (22.1x).
PBV 0/1
Price to book (19.2x) is above the industry median (2.6x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 2,587.4, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 3.86, above 1.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Creotech Instruments S.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Creotech Instruments S.A.
Creotech Instruments S.A. engages in the manufacture and sale of satellites, satellite systems, and subsystems in Poland. The company offers satellites, such as Nano MR MS, Eagle HR MS, and Seagull HR SAR; platforms, including HyperSat Nano, HyperSat Eagle, and custom solutions; and various services comprising mission analysis and design, registration, insurance, launch, operations, data warehousing, processing, and advanced data analysis services. It also provides science p…
Full company profileCreotech Instruments S.A. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Creotech Instruments S.A. annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 25.6M | 29.2M | 33.0M | 20.2M | 30.7M | 25.7M | 144M | 168M |
| Gross Profit | 21.4M | 23.2M | 25.3M | 10.5M | 19.6M | 19.0M | 20.5M | -2.73M |
| Operating Income | 252K | 2.20M | 985K | -8.69M | -16.9M | -24.8M | 18.8M | -6.98M |
| EBITDA | 2.01M | 3.85M | 1.55M | -4.10M | -7.62M | -15.3M | 32.0M | 7.90M |
| Net Income | 255K | 1.78M | 475K | -7.03M | -14.3M | -20.5M | 13.6M | 4.29M |
| EPS | 0.16 | 1.12 | 0.30 | -3.55 | -6.03 | -8.60 | 5.00 | 1.50 |
| Balance Sheet | ||||||||
| Total Assets | 21.4M | 30.8M | 46.0M | 76.7M | 173M | 162M | 333M | 315M |
| Total Liabilities | 16.0M | 23.6M | 27.8M | 28.2M | 81.2M | 91.4M | 148M | 164M |
| Shareholders' Equity | 5.42M | 7.20M | 18.2M | 48.5M | 91.4M | 71.0M | 159M | 151M |
| Cash & Short-term Investments | 2.90M | 6.37M | 11.9M | 26.3M | 73.2M | 32.4M | 115M | 29.4M |
| Total Debt | 1.58M | 3.22M | 5.30M | 2.85M | 24.0M | 22.5M | 20.9M | 24.0M |
| Cash Flow | ||||||||
| Operating Cash Flow | -6.47M | -4.56M | -11.3M | -16.8M | 15.5M | -18.6M | 50.9M | -156M |
| Capital Expenditure | 274K | 3.00M | 8.18M | 11.7M | 22.6M | 19.9M | 27.3M | 19.8M |
| Free Cash Flow | -6.74M | -7.55M | -19.5M | -28.5M | -7.14M | -38.5M | 23.7M | -176M |
| Ratios | ||||||||
| ROE | 4.7% | 24.7% | 2.6% | -14.5% | -15.7% | -28.8% | 8.5% | 2.8% |
| ROA | 1.2% | 5.8% | 1.0% | -9.2% | -8.3% | -12.6% | 4.1% | 1.4% |
| Net Profit Margin | 1.0% | 6.1% | 1.4% | -34.8% | -46.7% | -79.6% | 9.4% | 2.5% |
| Debt to Equity | 0.29x | 0.45x | 0.29x | 0.06x | 0.26x | 0.32x | 0.13x | 0.16x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Creotech Instruments S.A. dividends
Creotech Instruments S.A. has not paid dividends in the last 7 fiscal years.
Who owns Creotech Instruments S.A.
- Insiders 24.82%
- Institutions 33.10%
- Public & others 42.09%
- Shares outstanding 3.50M
- Free float 1.49M
Creotech Instruments S.A. company profile
- Company name
- Creotech Instruments S.A.
- Ticker
- CRI.WAR
- ISIN
- PLCRTCH00017
- Exchange
- Warsaw Stock Exchange
- Sector
- Industrials
- Industry
- Aerospace & Defense
- Employees
- 297
- Fiscal year end
- December
- Address
- ul. Jana Pawla II 66, Piaseczno, Poland, 05-500
- Phone
- 48 22 246 4575
- Website
- creotech.pl
About Creotech Instruments S.A.
Creotech Instruments S.A. engages in the manufacture and sale of satellites, satellite systems, and subsystems in Poland. The company offers satellites, such as Nano MR MS, Eagle HR MS, and Seagull HR SAR; platforms, including HyperSat Nano, HyperSat Eagle, and custom solutions; and various services comprising mission analysis and design, registration, insurance, launch, operations, data warehousing, processing, and advanced data analysis services. It also provides science products, such as Sinara/ARTIQ, MTCA/µTCA, White Rabbit by Creotech, standalone, FMC, and DI/OT, as well as controller, digital analog converter, analog digital converter, direct digital synthesizer, amplifier, delay, arbitrary waveform generator, digital input output, extension card, carrier, switch, PCIe board, and other products. In addition, the company offers CreoScan portable Ground Stations; Flight Monitoring System, a situational awareness system; Drone Rapid Mapping system, an integrated hardware and software solution; customized services; SAMPLE system which is used for the automated detection and monitoring of terrain obstacles; and Geomatic Remote Eye, a system which enables the collection of elevation data for given points or geographical areas. Further, it provides manufacturing services comprising full assembly for production of PCB, components, and blueprints; SMT and THT assembly; vacuum soldering; automatic optical and xray inspection; PCB cleaning; selective application of protective coatings; final assembly; press fit assembly; technical consulting and testing; traceability of individual devices from a batch; production of cable harnesses; and climatic research services. Creotech Instruments S.A. was founded in 2008 and is headquartered in Piaseczno, Poland.
Creotech Instruments S.A. management
4- Mr. Grzegorz Brona Ph.D.President of the Management Board & CEO
- Mr. Pawel Gornicki Ph.D.Vice-President of the Management Board & CFO
- Mr. Jacek MandasVice President of the Management Board
- Mr. Maciej MisiuraVice President of the Management Board